Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 408
Selected: 0
NCT IDTitle
NCT02758665Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Patients With CLL
NCT07336134PopSci CHW4CervixHealth
NCT01370772Intensified Rituimab Prephase Before FCR in Untreated B-CLL
NCT03449914The GOLD Study: G8 in OLDer Patients
NCT03324633Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV
NCT00275665The Study is Being Done to See if Taking the Drug Valganciclovir Can Prevent CMV Infection.
NCT03548428Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc)
NCT02049853The Triple A Initiative Study ("Aktionsbündnis Akute Atemnot")
NCT01596790COLOSPOT Study : Assessment by EPISPOT of Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer
NCT07426991Cognitive Performance, Sleep Disturbances and Fatigue in Multiple Sclerosis
NCT00453362A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib
NCT00050167Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer
NCT00127036Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)
NCT01195298Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer
NCT00291616Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B
NCT01723111Impact of Dialysis Modality on Hepcidin and Iron Metabolism
NCT05525858KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II
NCT04161248Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma
NCT01208896Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning for Relapsed Follicular Lymphoma
NCT00217152A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors
NCT02558816A Trial of Obinutuzumab,GDC-0199 Plus Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma Patients
NCT01249638Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC
NCT00400738The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients
NCT03385668Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase Antibodies
NCT01925820Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis B
NCT01059630A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) in Participants With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN)
NCT01306409Neocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents (ESA)
NCT01565200HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1
NCT00353457Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma
NCT03721653FOLFOXIRI + Bev + Atezo vs FOLFOXIRI + Bev as First-line Treatment of Unresectable Metastatic Colorectal Cancer Patients
NCT00855894A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer
NCT00752336Prospective Intervention Study to Improve HRQoL and Exercise Tolerance After Heart Transplantation
NCT01048879Pharmacokinetics of Tamiflu® (Oseltamivir) in Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)and or Continuous Venovenous Hemodialysis (CVVHD)
NCT00411762A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma
NCT00227370Comparison of Oral Valganciclovir and Placebo for the Prevention of Cytomegalovirus (CMV) After Lung Transplantation
NCT00620269Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III
NCT05017142Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
NCT01593332Low Dose Rituximab as a First Line Biologic Therapy for the Treatment of DMARD Resistant Patients With Rheumatoid Arthritis
NCT03779191Alectinib in Combination With Bevacizumab in ALK Positive NSCLC
NCT03679455A Study of Obinutuzumab (RO5072759) Induction in Patients With Relapsed/ Refractory Waldenström Macroglobulinemia, OBI-1
NCT03301493Genomic Testing and Resulting Medical Decisions
NCT00552201TACrolimus in Renal Transplantation: Individualization by Pharmacogenetic
NCT07365930NIS on the Benefits of TIPS in Patients With HCC Receiving Atezo+Bev in 1st-Line Therapy
NCT00273767Preliminary Administration of EPO and Markers of Cardiac Ischemia Induced by CPB
NCT04611867Study of PRO in Patients With Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)
NCT00391248Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-small Cell Lung Cancer (PEARL)
NCT01944943Phase II Study of Vismodegib in Patients With Refractory or Relapsed B-cell Lymphoma or Chronic Lymphocytic Leukemia
NCT07670117HAIQU (Hospital AIr QUality)
NCT00285233Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes
NCT04888221Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement